Back to PHM.MC
Phase 2
Development Phase
0
Upcoming Catalysts
0
Historical Events
1
Regulatory Approvals
No Catalysts Found
No catalyst events have been recorded for this drug yet.
Competitive Landscape
0 competitors in Frontal Fibrosing Alopecia
View Full LandscapeDrug Information
Patent & Exclusivity
No patent data available. Pre-approval drugs may not have Orange Book listings.
Regulatory Approvals
EMA9/19/2024
Anzupgo
Anzupgo is indicated for the treatment of moderate to severe chronic hand eczema (CHE) in adults and adolescents 12 years and older for whom topical corticosteroids are inadequate or inappropriate.
View on EMADrug Science
Mechanism of action & safety profile
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts
